UBS(Lux)E.F.-Biotech(USD)Q a.USD/ LU0400035332 /
| NAV2024-06-12 | Chg.+2.8900 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 322.9800USD | +0.90% | reinvestment | Equity Worldwide | UBS Fund M. (LU) ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2017 | - | - | - | - | - | - | - | - | - | - | -0.22 | 1.76 | - |
| 2018 | 5.81 | -5.18 | -3.03 | -2.69 | 4.96 | 2.50 | 3.06 | 4.53 | -2.00 | -13.47 | 5.70 | -9.66 | -11.15% |
| 2019 | 15.06 | 2.60 | -0.87 | -5.61 | -5.04 | 9.21 | -2.86 | -3.19 | -3.69 | 8.53 | 11.23 | 1.83 | +27.56% |
| 2020 | -3.71 | 0.22 | -6.90 | 14.65 | 10.10 | 3.18 | -2.84 | -0.70 | 0.17 | -4.86 | 10.79 | 5.60 | +25.89% |
| 2021 | -0.77 | -3.23 | -2.90 | 2.27 | -1.39 | 9.19 | -1.48 | 5.24 | -6.24 | -2.95 | -4.15 | 2.70 | -4.66% |
| 2022 | -11.58 | -2.63 | 4.19 | -9.82 | -3.82 | 5.95 | 1.51 | 5.29 | -0.89 | 5.51 | 7.03 | -6.06 | -7.37% |
| 2023 | 1.42 | -5.95 | 0.89 | 0.71 | -2.66 | 1.12 | 2.76 | -1.92 | -4.07 | -8.82 | 5.11 | 15.91 | +2.47% |
| 2024 | -2.78 | -0.57 | 1.85 | -8.35 | 9.27 | 3.51 | - | - | - | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 19.31% | 21.52% | 19.62% | 22.05% | 23.97% |
| Sharpe ratio | 0.05 | 1.16 | 0.19 | -0.32 | 0.12 |
| Best month | +15.91% | +15.91% | +15.91% | +15.91% | +15.91% |
| Worst month | -8.35% | -8.35% | -8.82% | -11.58% | -11.58% |
| Maximum loss | -15.15% | -15.15% | -17.23% | -35.86% | -35.86% |
| Outperformance | -1.88% | - | -5.84% | -5.66% | - |
All quotes in USD
Share classes
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| UBS(Lux)E.F.-Biotech(USD)P a.SEK | reinvestment | 958.6600 | +1.33% | +8.48% | |
| UBS(Lux)E.F.-Biotech(USD)QL a.US... | reinvestment | 105.0200 | +7.65% | -9.08% | |
| UBS(Lux)E.F.-Biotech(USD)Q a.USD | reinvestment | 322.9800 | +7.43% | -9.62% | |
| UBS (Lux) Equity Fund - Biotech ... | reinvestment | 102.7200 | +6.45% | - | |
| UBS (Lux) Equity Fund - Biotech ... | reinvestment | 728.4700 | +6.34% | -12.34% |
Performance
| YTD | +2.06% | ||
|---|---|---|---|
| 6 Months | +13.43% | ||
| 1 Year | +7.43% | ||
| 3 Years | -9.62% | ||
| 5 Years | +38.34% | ||
| 10 Years | - | ||
| Since start | +34.20% | ||
| Year | |||
| 2023 | +2.47% | ||
| 2022 | -7.37% | ||
| 2021 | -4.66% | ||
| 2020 | +25.89% | ||
| 2019 | +27.56% | ||
| 2018 | -11.15% | ||
